๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Acute renal toxicity associated with suramin in the treatment of prostate cancer

โœ Scribed by William D. Figg; Michael R. Cooper; Alain Thibault; Donna Headlee; Jeffrey Humphrey; Raymond C. Bergan; Eddie Reed; Oliver Sartor

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
287 KB
Volume
74
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of early treatment of prostate ca
Effect of early treatment of prostate cancer with the 5ฮฑ-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats
โœ Zaccheo, Tiziana; Giudici, Donata; di Salle, Enrico ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB

## Background: Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the dunning r3327 rat prostatic carcinoma model. we evaluated the preventive effect of turosteride when administered during the latency period in this p

Bone fractures associated with luteinizi
Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma
โœ Murphy F. Townsend; W. Holt Sanders; Robert O. Northway; Sam D. Graham Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

## Background: Luteinizing hormone-releasing hormone agonists (lhrh-a) have become an established treatment for certain patients with prostate carcinoma. lhrh-a are known to decrease bone mineral density. the purpose of this study was to determine the risk of bone fracture in men receiving lhrh-a f

Decreased HLA-A expression in prostate c
Decreased HLA-A expression in prostate cancer is associated with normal allele dosage in the majority of cases
โœ Lu, Qi-Long; Abel, Paul; Mitchell, Stephen; Foster, Christopher; Lalani, El-Nasi ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 213 KB ๐Ÿ‘ 1 views

A comparison has been made of the phenotypic expression of MHC class I antigens with the corresponding HLA-A genotype in 15 cases of benign prostatic hyperplasia (BPH) and 34 cases of primary locally invasive prostatic carcinoma. Expression of class 1 protein, detected by immunocytochemistry, was pa